Related Experiment Video
Updated: May 16, 2026
09:44
Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
Published on: March 5, 2022
PCOS: metabolic impact and long-term management
1Androgen Excess and PCOS Society, DISMOT Department, University of Palermo, Italy. enricocarmina@libero.it
Minerva Ginecologica
|December 13, 2012
Summary
Polycystic ovary syndrome (PCOS) increases cardiovascular risk in women. Individual risk assessment is crucial, as metabolic changes with age in PCOS require further study.
Area of Science:
- Endocrinology
- Reproductive Health
- Cardiovascular Medicine
Background:
- Polycystic ovary syndrome (PCOS) is a common endocrine disorder affecting up to 10% of reproductive-aged women.
- PCOS is associated with increased risks of type II diabetes, cardiovascular diseases, and endometrial cancer.
- While cardiovascular risk is elevated in women with PCOS, individual risk profiles vary and require assessment.
Purpose of the Study:
- To investigate the changes in metabolic profiles of women with PCOS over time.
- To better understand the relationship between aging, hormonal changes, and cardiovascular risk in PCOS patients.
- To highlight the need for more data on the long-term metabolic health of women with PCOS.
Main Methods:
- This study focuses on analyzing existing data and literature regarding metabolic changes in women with PCOS.
- The research involves a review of current understanding of cardiovascular risk factors in relation to age and hormonal fluctuations in PCOS.
- Further research is needed to collect comprehensive data on metabolic profiles across different age groups.
Main Results:
- Women with PCOS exhibit an increased lifetime risk for several chronic conditions.
- There is a noted discrepancy between cardiovascular risk in younger women with PCOS and actual postmenopausal events, potentially linked to hormonal shifts.
- Current data on age-related metabolic changes in PCOS is insufficient.
Conclusions:
- Individualized cardiovascular risk assessment is essential for women with PCOS.
- Hormonal changes, particularly androgen function post-forties, may influence cardiovascular risk progression.
- More research is critically needed to elucidate age-related metabolic alterations in women with PCOS.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:29Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:30Hormonal Control of the Ovarian Cycle
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...